UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022777
Receipt number R000026253
Scientific Title Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction
Date of disclosure of the study information 2016/06/17
Last modified on 2021/06/21 12:22:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction

Acronym

Acute myocardial infarction and plasma XOR activity

Scientific Title

Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction

Scientific Title:Acronym

Acute myocardial infarction and plasma XOR activity

Region

Japan


Condition

Condition

Acute myocardial infarction

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical significance of plasma xantine oxidoreductase levels in patients with acute myocardial infarction.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationships between plasma xantine oxidoreductase activity and prognosis in patients with acute myocardial infarction

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patiets who admitted to our hospital diagnosed with acute myocardial infarction and emergent coronary intervention was performed.
2)Patients who give written informed consent.

Key exclusion criteria

1)Patinets who the physician judged to be inappropriate to this study.
2)The patient who withdrew informed consent.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Yokoyama

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Cardiology

Zip code

036-8562

Address

5 Zaifu-cho Hirosaki, Aomori

TEL

0172-39-5057

Email

hero8686@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Yokoyama

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Cardiology

Zip code

036-8562

Address

5 Zaifu-cho Hirosaki, Aomori

TEL

0172-39-5057

Homepage URL


Email

hero8686@hirosaki-u.ac.jp


Sponsor or person

Institute

Department of Cardiology, Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hirosaki University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Sanwa Kagaku Kenkyusyo Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hirosaki University Certified Review Board

Address

1 Bunkyo-sho, Hirosaki

Tel

0172-39-5362

Email

crb-hirosaki@hirosaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学医学部附属病院(青森県)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Under making Manuscript.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 01 Month 14 Day

Date of IRB

2016 Year 04 Month 04 Day

Anticipated trial start date

2016 Year 04 Month 04 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: Observation

Objective recruitment: Patients who admitted to our hospital diagnosed with acute myocardial infarction and emergent coronary intervention was performed.

Primary outcome: Relationships between plasma xantine oxidoreductase activity and prognosis in patients with acute myocardial infarction.


Management information

Registered date

2016 Year 06 Month 17 Day

Last modified on

2021 Year 06 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026253


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name